|Bid||7.68 x 1300|
|Ask||7.84 x 3100|
|Day's Range||7.65 - 7.89|
|52 Week Range||3.45 - 14.68|
|Beta (5Y Monthly)||0.31|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 06, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||19.83|
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). We reversed our stance on March 25th after seeing unprecedented fiscal and monetary stimulus unleashed by the Fed and the Congress. […]
Investors need to pay close attention to Kala Pharmaceuticals (KALA) stock based on the movements in the options market lately.